Hemostats Market is Expected to Reach USD 3.03 Billion by 2023
The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.
(businesspress24) - The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.
The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Hemostats Market, along with revenue estimates & forecasts and market share analysis.
Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9571619
Hemostats Market segmentation:
The Major Players Opearting in the Hemostats Market:
Key players in the Hemostats Market include CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).
Johnson & Johnson was the leading player in the global Hemostats Market. The company has a strong presence in North America, Europe, Asia, and Latin America.
Ethicon, a subsidiary of Johnson & Johnson develops, manufactures, and markets technologically innovative hemostats. The companys in key markets. A good brand image for hemostats in the market has helped the company to maintain its leading position in the market. Ethicon focuses on expanding its presence in the hemostats market through the product launches. In June 2017, the company launched SURGICEL powder, a new absorbable adjunctive hemostat.
Geographical Detailed Analysis for Hemostats Market:
North America is the largest regional segment in the Hemostats Market followed by Europe, Asia, and the Rest of the World (Row).
The hemostats market in North America is well-established, with the US being a major market in this region. Growth in the North American market is majorly driven by the growing geriatric population and increasing number of surgeries in the region.
Read More in Detailed (Hemostats):
https://www.marketsandmarkets.com/PressReleases/hemostats.asp
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 28.06.2019 - 08:46 Uhr
Sprache: Deutsch
News-ID 1536113
Anzahl Zeichen: 3203
Kontakt-Informationen:
Ansprechpartner: Mr. Shelly Singh
Stadt:
northbrook
Telefon: 8886006441
Kategorie:
Vermischtes
Meldungsart: bitte
Versandart: Veröffentlichung
Freigabedatum:
Anmerkungen:
Diese Pressemitteilung wurde bisher 52 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Hemostats Market is Expected to Reach USD 3.03 Billion by 2023
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
